AB-2(Algen Biotechnologies)

N/A

Report date: 2025/12/17 11:13:23
NME

Base Information

Drug NameAB-2(Algen Biotechnologies)
Drug Alias NameAB-2
ClassificationCell and gene therapy > Gene therapy > Gene editing > CRISPR
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAlgen Biotechnologies Inc
China Registration ClassN/A

Develop Information

Active CompaniesAlgen Biotechnologies Inc
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A